Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
UroPartners is a large Midwest urology group practice providing commercial-stage specialty healthcare services across Chicagoland and parts of Illinois and Southern Wisconsin. The organization delivers comprehensive urologic care through a network of more than 30 locations and over 90 providers, with services spanning office-based urology, radiation oncology, pathology, prostate cancer centers, and imaging/interventional radiology. Rather than a drug-development biotech, UroPartners is a patient-care delivery organization focused on diagnosis, treatment, and longitudinal management of urologic diseases. The company was privately held and in February 2023 joined Solaris Health, a national urology services platform now branded Urology Alliance. Its business is centered on specialty physician practice operations, cancer care, diagnostics, and integrated outpatient urology services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on UroPartners.